William Robinson MD

Professor, Medicine, University of Colorado School of Medicine

1665 Aurora CtAurora, CO 80045
Phone+1 720-848-0300
Fax+1 702-848-1786

Dr. Robinson is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Robinson's full profile Already have an account?

Education & Training

University of ColoradoResidency, Internal Medicine, 1964 - 1965
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1962 - 1964
University of Colorado School of Medicine Anschutz Medical CampusClass of 1962

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CO State Medical License 1963 - 2027

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017

Publications & Presentations

PubMed

Decitabine reverses innate immune gene suppression in rare melanomas.
Morgan L MacBeth, Stacey M Bagby, Jessica S W Borgers, Jacqueline A Turner, Kelsey Anderson
Molecular Cancer Therapeutics. 2026-07-14
Weekly Cladribine Followed by Rituximab for the Treatment of Hairy Cell Leukemia.
Jacqueline A Turner, Jennifer Santos, Vincenzo Pizzuti, Emily Paton, William A Robinson
Ejhaem. 2026-06-01
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial.
Jessica S W Borgers, Cheng-Chang Wu, Theresa M Medina, Claire M Muckle, Elizabeth N Katsnelson
Journal of the National Comprehensive Cancer Network. 2026-03-31

Journal Articles

BRAF Fusions Identified in Melanomas Have Variable Treatment Responses and Phenotypes
Hannah Lee, William A Robinson, Martin McCarter, Nature

Other

Screening for cervical cancer in HIV infected women
Robinson WR
http://www.uptodate.com/contents/screening-for-cervical-cancer-in-hiv-infected-women
UpToDate, Wolters Kluwer Health - 2013-01-10
Preinvasive and invasive cervical neoplasia in HIV-infected women
Robinson WR
http://www.uptodate.com/contents/preinvasive-and-invasive-cervical-neoplasia-in-hiv-infected-women
UpToDate, Wolters Kluwer Health - 2012-07-24
Vulvar and vaginal intraepithelial neoplasia in HIV-infected women
Robinson WR
http://www.uptodate.com/contents/vulvar-and-vaginal-intraepithelial-neoplasia-in-hiv-infected-women
UpToDate, Wolters Kluwer Health - 2012-04-16

Press Mentions

Eyes Widen for Uveal Melanoma Treatment: Sapna Patel’s Groundbreaking Findings at ESMO 2025October 21st, 2025
Top Melanoma Abstracts From ASCO 2025June 24th, 2025
A Fellow Stays Focused on Her GoalsDecember 3rd, 2024